Related references
Note: Only part of the references are listed.Preliminary exploration of the potential of spliceosome-associated protein 130 for predicting disease severity in Crohn's disease
Wenbin Gong et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2020)
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
Christian Maaser et al.
JOURNAL OF CROHNS & COLITIS (2019)
Correlation between endoscopic and histological validated scoring indices in Crohn's disease
Wenbin Gong et al.
DIGESTIVE AND LIVER DISEASE (2019)
Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease
Marin J. de Jong et al.
JOURNAL OF CROHNS & COLITIS (2019)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease
Reena Khanna et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease
Reena Khanna et al.
GUT (2016)
IOIBD technical review on endoscopic indices for Crohn's disease clinical trials
L. Vuitton et al.
GUT (2016)
C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
Mahmoud H. Mosli et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Converging Goals of Treatment of Inflammatory Bowel Disease From Clinical Trials and Practice
Barrett G. Levesque et al.
GASTROENTEROLOGY (2015)
Disease Activity Assessment in IBD: Clinical Indices and Biomarkers Fail to Predict Endoscopic Remission
James D. Falvey et al.
INFLAMMATORY BOWEL DISEASES (2015)
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity
R. Khanna et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
IBD and health-related quality of life - Discovering the true impact
Sanna Lonnfors et al.
JOURNAL OF CROHNS & COLITIS (2014)
Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD
Pauliina Molander et al.
JOURNAL OF CROHNS & COLITIS (2013)
Mucosal healing in inflammatory bowel diseases: a systematic review
Markus F. Neurath et al.
GUT (2012)
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
Geert D'Haens et al.
INFLAMMATORY BOWEL DISEASES (2012)
Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease
Laurent Peyrin-Biroulet et al.
JOURNAL OF CROHNS & COLITIS (2011)
Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease
Jennifer Jones et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
A review of activity indices and efficacy Endpoints for clinical trials of medical therapy in adults with Crohn's disease
WJ Sandborn et al.
GASTROENTEROLOGY (2002)